21,738
Views
0
CrossRef citations to date
0
Altmetric
Canadian Tuberculosis Standards - 8th Edition

Chapter 2: Transmission and pathogenesis of tuberculosis

, &

References

  • Bumbacea D, Arend SM, Eyuboglu F, et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J. 2012;40(4):990–1013. doi:10.1183/09031936.00000712.
  • Allen E. Tuberculosis and other mycobacterial infections of the lung. In: Thurlbeck W, Churg A, eds. Pathology of the Lung 2ed. New York: Thieme Medical Publishers; 1995. 229–302.
  • Iseman M. How is tuberculosis transmitted? In: Iseman MD, ed. A Clinician’s Guide to Tuberculosis. New York, NY: Lippincott Williams and Wilkins; 2000:51–62.
  • Curtis AB, Ridzon R, Vogel R, et al. Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med. 1999;341(20):1491–1495. doi:10.1056/NEJM199911113412002.
  • Starke JR. Transmission of mycobacterium tuberculosis to and from children and adolescents. Seminars in Pediatric Infectious Diseases. 2001;12(2):115–123. doi:10.1053/spid.2001.22785.
  • Martinez L, Woldu H, Chen C, et al. Transmission Dynamics in Tuberculosis Patients With Human Immunodeficiency Virus: A Systematic Review and Meta-analysis of 32 Observational Studies. Clin Infect Dis. 2021;73(9):e3446–e3455. doi:10.1093/cid/ciaa1146.
  • Menzies D. Issues in the Management of Contacts of Patients with Active Pulmonary Tuberculosis. Can J Public Health. 1997;88(3):197–201. doi:10.1007/BF03403887
  • Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: The effects of chemotherapy. Tubercle. 1976;57(4):275–299. doi:10.1016/S0041-3879(76)80006-2.
  • Van Zwanenberg D. The influence of the number of bacilli on the development of tuberculous disease in children. Am Rev Respir Dis. 1960;82:31–44. doi:10.1164/arrd.1960.82.1.31.
  • Shaw JB, Wynn-Williams N. Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc. 1954;69(5):724–732. doi:10.1164/art.1954.69.5.724.
  • Grzybowski S, Barnett GD, Styblo K. Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc. 1975;50(1):90–106.
  • van Geuns HA, Meijer J, Styblo K. Results of contact examination in Rotterdam, 1967-1969. Bull Int Union Tuberc. 1975;50(1):107–121.
  • Loudon RG, Spohn SK. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Respir Dis. 1969;99(1):109–111. doi:10.1164/arrd.1969.99.1.109.
  • Rose CE, Zerbe GO, Lantz SO, Bailey WC. Establishing priority during investigation of tuberculosis contacts. Am Rev Respir Dis. 1979;119(4):603–609. doi:10.1164/arrd.1979.119.4.603.
  • Snider DE, Kelly GD, Cauthen GM, Thompson NJ, Kilburn JO. Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. Am Rev Respir Dis. 1985;132(1):125–132. doi:10.1164/arrd.1985.132.1.125.
  • Yeager H, Lacy J, Smith LR, LeMaistre CA. Quantitative studies of mycobacterial populations in sputum and saliva. Am Rev Respir Dis. 1967;95(6):998–1004. doi:10.1164/arrd.1967.95.6.998.
  • Behr MA, Warren SA, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet (London, England). 1999;353(9151):444–449. doi:10.1016/S0140-6736(98)03406-0.
  • Hernández-Garduño E, Cook V, Kunimoto D, Elwood RK, Black WA, FitzGerald JM. Transmission of tuberculosis from smear negative patients: a molecular epidemiology study. Thorax. 2004;59(4):286–290. doi:10.1136/thx.2003.011759.
  • Tostmann A, Kik SV, Kalisvaart NA, et al. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis: An Official Publication of the Infectious Diseases Society of America. 2008;47(9):1135–1142. doi:10.1086/591974.
  • Asadi L, Croxen M, Heffernan C, et al. How Much Do Smear-Negative Patients Really Contribute to Tuberculosis Transmissions? Re-Examining an Old Question with New Tools. EClinicalMedicine. 2022;43:101250. doi:10.1016/j.eclinm.2021.101250.
  • Lohmann EM, Koster BFPJ, Le Cessie S, Kamst-van Agterveld MP, van Soolingen D, Arend SM. Grading of a positive sputum smear and the risk of Mycobacterium tuberculosis transmission. Int J Tuberc Lung Dis. 2012;16(11):1477–1484. doi:10.5588/ijtld.12.0129.
  • Lee HS, Kee SJ, Shin JH, et al. Xpert MTB/RIF Assay as a Substitute for Smear Microscopy in an Intermediate-Burden Setting. Am J Respir Crit Care Med. 2019;199(6):784–794. doi:10.1164/rccm.201804-0654OC.
  • Van Deun A, Tahseen S, Affolabi D, et al. Sputum smear microscopy in the Xpert® MTB/RIF era. Int J Tuberc Lung Dis: The Official Journal of the International Union against Tuberculosis and Lung Disease. 2019;23(1):12–18. doi:10.5588/ijtld.18.0553.
  • Catanzaro A. Nosocomial tuberculosis. Am Rev Respir Dis. 1982;125(5):559–562. doi:10.1164/arrd.1982.125.5.559.
  • Bailey WC, Gerald LB, Kimerling ME, et al. Predictive model to identify positive tuberculosis skin test results during contact investigations. JAMA. 2002;287(8):996–1002. doi:10.1001/jama.287.8.996.
  • Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH. Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med. 2000;162(6):2033–2038. doi:10.1164/ajrccm.162.6.2004022.
  • Palaci M, Dietze R, Hadad DJ, et al. Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis. J Clin Microbiol. 2007;45(12):4064–4066. doi:10.1128/JCM.01780-07.
  • Heffernan C, Barrie J, Doroshenko A, et al. Prompt recognition of infectious pulmonary tuberculosis is critical to achieving elimination goals: a retrospective cohort study. BMJ Open Resp Res. 2020;7(1):e000521. doi:10.1136/bmjresp-2019-000521.
  • Lau A, Barrie J, Winter C, Elamy AH, Tyrrell G, Long R. Chest Radiographic Patterns and the Transmission of Tuberculosis: Implications for Automated Systems. PLoS One. 2016;11(4):e0154032. doi:10.1371/journal.pone.0154032.
  • Muecke C, Isler M, Menzies D, Allard R, Tannenbaum TN, Brassard P. The use of environmental factors as adjuncts to traditional tuberculosis contact investigation. Int J Tuberc Lung Dis: The Official Journal of the International Union against Tuberculosis and Lung Disease. 2006;10(5):530–535.
  • Rieder HL. The infectiousness of laryngeal tuberculosis: appropriate public health action based on false premises [Counterpoint]. Int J Tuberc Lung Dis. 2009;13(1):4–5.
  • Loudon RG, Roberts RM. Singing and the Dissemination of Tuberculosis. Am Rev Respir Dis. 1968;98(2):297–300. doi:10.1164/arrd.1968.98.2.297.
  • Loudon RG, Roberts RM. Droplet expulsion from the respiratory tract. Am Rev Respir Dis. 1967;95(3):435–442. doi:10.1164/arrd.1967.95.3.435.
  • Turner RD, Birring SS, Darmalingam M, et al. Daily cough frequency in tuberculosis and association with household infection. Int j Tuberc Lung Dis. 2018;22(8):863–870. doi:10.5588/ijtld.17.0652.
  • Riley RL, Mills CC, Nyka W, et al. Aerial dissemination of pulmonary tuberculosis. A two-year study of contagion in a tuberculosis ward. 1959. Am J Epidemiol. 1995;142(1):3–14. doi:10.1093/oxfordjournals.aje.a117542.
  • Sultan L, Nyka W, Mills C, O’grady F, Wells W, Riley RL. Tuberculosis disseminators. A study of the variability of aerial infectivity of tuberculous patients. Am Rev Respir Dis. 1960;82:358–369. doi:10.1164/arrd.1960.82.3.358.
  • Riley RL, Mills CC, O’grady F, Sultan LU, Wittstadt F, Shivpuri DN. Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients. Am Rev Respir Dis. 1962;85:511–525. doi:10.1164/arrd.1962.85.4.511.
  • Lin H-H, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med. 2007;4(1):e20. doi:10.1371/journal.pmed.0040020.
  • Stein RA. Super-spreaders in infectious diseases. Int J Infect Dis. 2011;15(8):e510-3. doi:10.1016/j.ijid.2010.06.020.
  • Jindani A, Aber VR, Edwards EA, Mitchison DA. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis. 1980;121(6):939–949. doi:10.1164/arrd.1980.121.6.939.
  • Soysal A, Millington KA, Bakir M, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet (London, England). 2005;366(9495):1443–1451. doi:10.1016/S0140-6736(05)67534-4.
  • Eisenhut M, Paranjothy S, Abubakar I, et al. BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay. Vaccine. 2009;27(44):6116–6120. doi:10.1016/j.vaccine.2009.08.031.
  • Eriksen J, Chow JY, Mellis V, et al. Protective effect of BCG vaccination in a nursery outbreak in 2009: time to reconsider the vaccination threshold? Thorax. 2010;65(12):1067–1071. doi:10.1136/thx.2010.140186.
  • Basu Roy R, Sotgiu G, Altet-Gómez N, et al. Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study. Am J Respir Crit Care Med. 2012;186(4):378–384. doi:10.1164/rccm.201201-0026OC.
  • Albanna AS, Reed MB, Kotar KV, et al. Reduced transmissibility of East African Indian strains of Mycobacterium tuberculosis. PloS One. 2011;6(9):e25075. doi:10.1371/journal.pone.0025075.
  • Middlebrook G, Cohn ML. Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science (New York, NY). 1953;118(3063):297–299. doi:10.1126/science.118.3063.297.
  • Schaaf HS, Marais BJ, Hesseling AC, Gie RP, Beyers N, Donald PR. Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa. Acta Paediatrica (Oslo, Norway: 1992). 2006;95(5):523–528. doi:10.1080/08035250600675741.
  • Moss AR, Alland D, Telzak E, et al. A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York. Int J Tuberc Lung Dis: The Official Journal of the International Union against Tuberculosis and Lung Disease. 1997;1(2):115–121.
  • Drobniewski F, Balabanova Y, Nikolayevsky V, et al. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA. 2005;293(22):2726–2731. doi:10.1001/jama.293.22.2726.
  • Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet (London, England). 2006;368(9547):1575–1580. doi:10.1016/S0140-6736(06)69573-1.
  • Langlois-Klassen D, Senthilselvan A, Chui L, et al. Transmission of Mycobacterium tuberculosis Beijing Strains, Alberta, Canada, 1991–2007. Emerg Infect Dis. 2013;19(5):701–711. doi:10.3201/eid1905.121578.
  • Rea E, Leung T. A cluster of tuberculosis cases linked to smoking: An under-recognized challenge for tuberculosis elimination. Can Commun Dis Rep. 2018;44(3-4):86–90. doi:10.14745/ccdr.v44i34a03.
  • Reichler MR, Khan A, Yuan Y, Tuberculosis Epidemiologic Studies Consortium Task Order 2 Team, et al. Duration of Exposure Among Close Contacts of Patients With Infectious Tuberculosis and Risk of Latent Tuberculosis Infection. Clin Infect Dis: An Official Publication of the Infectious Diseases Society of America. 2020;71(7):1627–1634. doi:10.1093/cid/ciz1044.
  • Templeton GL, Illing LA, Young L, Cave D, Stead WW, Bates JH. The risk for transmission of Mycobacterium tuberculosis at the bedside and during autopsy. Ann Intern Med. 1995;122(12):922–925. doi:10.7326/0003-4819-122-12-199506150-00005.
  • Heffernan C, Rowe BH, Long R. Engaging frontline providers: an important key to eliminating tuberculosis in Canada, and other high-income countries. Can J Public Health. 2021;112(5):872–876. doi:10.17269/s41997-021-00556-x.
  • Wells WF. Airborne Contagion and Air Hygiene an Ecological Study of Droplet Infections. Cambridge : Harvard University Press (for The Commonwealth Fund), Mass., U.S.A. London : Geoffrey Cumberlege, Oxford University Press; 1955.
  • Murray JF. Bill Dock and the location of pulmonary tuberculosis: how bed rest might have helped consumption. Am J Respir Crit Care Med. 2003;168(9):1029–1033. doi:10.1164/rccm.200307-1016OE.
  • Woolwine SC, Bishai WR. Overview of the pathogenesis of tuberculosis from a cellular and molecular perspective. In: Raviglione M, ed. Reichman and Hershfield’s Tuberculosis. 3 ed. New York: Informal Healthcare; 2006. 101–116.
  • Behr MA, Waters WR. Is tuberculosis a lymphatic disease with a pulmonary portal? Lancet Infect Dis. 2014;14(3):250–255. doi:10.1016/S1473-3099(13)70253-6.
  • Collins J, Ej S. Chest Radiology. Lippincott, Williams and Wilkins; 2008.
  • Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med. 2012;367(4):348–361. doi:10.1056/NEJMra1008049.
  • Martinez L, Cords O, Horsburgh CR, et al. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet (London, England). 2020;395(10228):973–984. doi:10.1016/S0140-6736(20)30166-5.
  • Gupta RK, Calderwood CJ, Yavlinsky A, et al. Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings. Nat Med. 2020;26(12):1941–1949. doi:10.1038/s41591-020-1076-0.
  • Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992;326(4):231–235. doi:10.1056/NEJM199201233260404.
  • Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis: The Official Journal of the International Union against Tuberculosis and Lung Disease. 2004;8(4):392–402.
  • Post FA, Wood R, Pillay GP. Pulmonary tuberculosis in HIV infection: radiographic appearance is related to CD4+ T-lymphocyte count. Tuber Lung Dis: The Official Journal of the International Union against Tuberculosis and Lung Disease. 1995;76(6):518–521. doi:10.1016/0962-8479(95)90527-8.
  • Burman WJ, Jones BE. Clinical and radiographic features of HIV-related tuberculosis. Seminars in Respiratory Infections. 2003;18(4):263–271. doi:10.1053/S0882-0546(03)00072-0.
  • Stead WW, Kerby GR, Schlueter DP, Jordahl CW. The clinical spectrum of primary tuberculosis in adults. Confusion with reinfection in the pathogenesis of chronic tuberculosis. Ann Intern Med. 1968;68(4):731–745. doi:10.7326/0003-4819-68-4-731.
  • Ayres JS, Schneider DS. Tolerance of Infections. Annu Rev Immunol. 2012;30(1):271–294. doi:10.1146/annurev-immunol-020711-075030.
  • Cadena AM, Fortune SM, Flynn JL. Heterogeneity in tuberculosis. Nat Rev Immunol. Nov 2017;17(11):691–702. doi:10.1038/nri.2017.69.
  • Divangahi M. Are tolerance and training required to end TB? Nat Rev Immunol. 2018;18(11):661–663. doi:10.1038/s41577-018-0070-y.
  • Wilson RJ, Pillay DG, Sturm AW. Mycobacterium tuberculosis is not an obligate aerobe. J Infect. 1999;38(3):197–198. doi:10.1016/S0163-4453(99)90253-0.
  • Wayne LG, Diaz GA. Autolysis and Secondary Growth of Mycobacterium tuberculosis in Submerged Culture. J Bacteriol. 1967;93(4):1374–1381.
  • Wayne LG, Lin KY. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect Immun. 1982;37(3):1042–1049. doi:10.1128/iai.37.3.1042-1049.1982.
  • Ferguson RG. Studies in Tuberculosis. Toronto, ON: University of Toronto Press; 1955.
  • Long R, Lau A. Ferguson’s groundbreaking studies influenced our understanding of tuberculosis reinfection. Where to next? Int J Tuberc Lung Dis. 2016;20(10):1285–1287. doi:10.5588/ijtld.16.0447.
  • Houk VH, Kent DC, Baker JH, Sorensen K, Hanzel GD. The Byrd study. In-depth analysis of a micro-outbreak of tuberculosis in a closed environment. Arch Environ Health. 1968;16(1):4–6. doi:10.1080/00039896.1968.10665007.
  • Houk VN, Baker JH, Sorensen K, Kent DC. The epidemiology of tuberculosis infection in a closed environment. Arch Environ Health. 1968;16(1):26–35. doi:10.1080/00039896.1968.10665011.
  • Lee RS, Proulx J-F, Menzies D, Behr MA. Progression to tuberculosis disease increases with multiple exposures. Eur Respir J. 2016;48(6):1682–1689. doi:10.1183/13993003.00893-2016.
  • Acuña-Villaorduña C, Jones-López EC, Fregona G, et al. Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease. Eur Respir J. 2018;51(1):1701578. doi:10.1183/13993003.01578-2017.
  • Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis: An Official Publication of the Infectious Diseases Society of America. 2012;54(6):784–791. doi:10.1093/cid/cir951.
  • Jasmer RM, Bozeman L, Schwartzman K, et al. Recurrent tuberculosis in the United States and Canada: relapse or reinfection? Am J Respir Crit Care Med. 2004;170(12):1360–1366. doi:10.1164/rccm.200408-1081OC.
  • Narayanan S, Swaminathan S, Supply P, et al. Impact of HIV Infection on the Recurrence of Tuberculosis in South India. J Infect Dis. 2010;201(5):691–703. doi:10.1086/650528.
  • Crampin AC, Mwaungulu JN, Mwaungulu FD, et al. Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS (London, England). 2010;24(3):417–426. doi:10.1097/QAD.0b013e32832f51cf.
  • Den Boon S, Matteelli A, Ford N, Getahun H. Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV: a systematic review and meta-analysis. AIDS (London, England). 2016;30(5):797–801. doi:10.1097/QAD.0000000000000985.
  • Lee RS, Radomski N, Proulx J-F, et al. Reemergence and amplification of tuberculosis in the Canadian arctic. J Infect Dis. 2015;211(12):1905–1914. doi:10.1093/infdis/jiv011.
  • Khan FA, Fox GJ, Lee RS, et al. Housing and tuberculosis in an Inuit village in northern Quebec: a case-control study. CMAJ Open. 2016;4(3):E496–E506. doi:10.9778/cmajo.20160049.
  • Dannenberg AM, Sugimoto M. Liquefaction of Caseous Foci in Tuberculosis. Am Rev Respir Dis. 1976;113(3):257–259. doi:10.1164/arrd.1976.113.3.257.
  • Long R, Maycher B, Dhar A, Manfreda J, Hershfield E, Anthonisen N. Pulmonary tuberculosis treated with directly observed therapy: serial changes in lung structure and function. Chest. 1998;113(4):933–943. doi:10.1378/chest.113.4.933.
  • Chan IHY, Kaushik N, Dobler CC. Post-migration follow-up of migrants identified to be at increased risk of developing tuberculosis at pre-migration screening: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(7):770–779. doi:10.1016/S1473-3099(17)30194-9.
  • Long R, Asadi L, Heffernan C, et al. Is there a fundamental flaw in Canada’s post-arrival immigrant surveillance system for tuberculosis? PLoS One. 2019;14(3):e0212706. doi:10.1371/journal.pone.0212706.
  • Behr MA, Kaufmann E, Duffin J, Edelstein PH, Ramakrishnan L. Latent Tuberculosis: Two Centuries of Confusion. Am J Respir Crit Care Med. 2021;204(2):142–148. doi:10.1164/rccm.202011-4239PP.
  • Behr MA, Edelstein PH, Ramakrishnan L. Revisiting the timetable of tuberculosis. BMJ. 2018;362:k2738. doi:10.1136/bmj.k2738.
  • Drain PK, Bajema KL, Dowdy D, et al. Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection. Clin Microbiol Rev. 2018;31(4):1–24. doi:10.1128/CMR.00021-18.
  • Kendall EA, Shrestha S, Dowdy DW. The Epidemiological Importance of Subclinical Tuberculosis. A Critical Reappraisal. Am J Respir Crit Care Med. 2021;203(2):168–174. doi:10.1164/rccm.202006-2394PP.
  • Lönnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet (London, England). 2010;375(9728):1814–1829. doi:10.1016/S0140-6736(10)60483-7.
  • Fox GJ, Lee RS, Lucas M, et al. Inadequate Diet Is Associated with Acquiring Mycobacterium tuberculosis Infection in an Inuit Community. A Case-Control Study. Ann Am Thorac Soc. 2015;12(8):1153–1162. doi:10.1513/AnnalsATS.201503-156OC.
  • Saunders MJ, Wingfield T, Datta S, et al. A household-level score to predict the risk of tuberculosis among contacts of patients with tuberculosis: a derivation and external validation prospective cohort study. Lancet Infect Dis. 2020;20(1):110–122. doi:10.1016/S1473-3099(19)30423-2.
  • Martineau AR, Nhamoyebonde S, Oni T, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. PNAS. 2011;108(47):19013–19017. doi:10.1073/pnas.1111825108.
  • Fares A. Seasonality of tuberculosis. J Glob Infect Dis. 2011;3(1):46–55. doi:10.4103/0974-777X.77296.
  • Willis MD, Winston CA, Heilig CM, Cain KP, Walter ND, Mac Kenzie WR. Seasonality of tuberculosis in the United States, 1993-2008. Clin Infect Dis: An Official Publication of the Infectious Diseases Society of America. 2012;54(11):1553–1560. doi:10.1093/cid/cis235.
  • Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med. 1990;322(7):422–427. doi:10.1056/NEJM199002153220702.
  • Greenwood CM, Fujiwara TM, Boothroyd LJ, et al. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet. 2000;67(2):405–416. doi:10.1086/303012.
  • Bellamy R. Susceptibility to mycobacterial infections: the importance of host genetics. Genes & Immunity. 2003;4(1):4–11. doi:10.1038/sj.gene.6363915.
  • Pan H, Yan B-S, Rojas M, et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature. 2005;434(7034):767–772. doi:10.1038/nature03419.
  • Tameris MD, Hatherill M, Landry BS, et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet (London, England). 2013;381(9871):1021–1028. doi:10.1016/S0140-6736(13)60177-4.
  • Nemes E, Geldenhuys H, Rozot V, et al. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination. N Engl J Med. 2018;379(2):138–149. doi:10.1056/NEJMoa1714021.
  • Divangahi M, Khan N, Kaufmann E. Beyond Killing Mycobacterium tuberculosis: Disease Tolerance. Front Immunol. 2018;9:2976. doi:10.3389/fimmu.2018.02976.
  • Cobat A, Gallant CJ, Simkin L, et al. Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis. J Exp Med. 2009;206(12):2583–2591. doi:10.1084/jem.20090892.
  • Morrison J, Pai M, Hopewell PC. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8(6):359–368. doi:10.1016/S1473-3099(08)70071-9.
  • Divangahi M, Behr MA. Cracking the Vaccine Code in Tuberculosis. Am J Respir Crit Care Med. 2018;197(4):427–432. doi:10.1164/rccm.201707-1489PP.
  • Netea MG, Dominguez-Andres J, Barreiro LB, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020;20(6):375–388. doi:10.1038/s41577-020-0285-6.
  • Divangahi M, Aaby P, Khader SA, et al. Trained immunity, tolerance, priming and differentiation: distinct immunological processes. Nat Immunol. 2021;22(1):2–6. doi:10.1038/s41590-020-00845-6.
  • Kaufmann E, Sanz J, Dunn JL, et al. BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis. Cell. 2018;172(1-2):176–190.e19. doi:10.1016/j.cell.2017.12.031.
  • Khan N, Downey J, Sanz J, et al. Tuberculosis Reprograms Hematopoietic Stem Cells to Limit Myelopoiesis and Impair Trained Immunity. Cell. 2020;183(3):752–770.e22. doi:10.1016/j.cell.2020.09.062.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.